Special Issue "Update of Urolithiasis and Treatment"
Deadline for manuscript submissions: 30 June 2023 | Viewed by 1128
Interests: urolithiasis; minimal invasive stone surgery; medical expulsive therapy; extracorporeal shockwave lithotripsy
Interests: retrograde intrarenal surgery; minimal invasive percutaneous nephrolithotomy; laparoscopic/robotic stone surgery; pharmacological stone prevention
The incidence of urolithiasis is increasing globally, with approximately 10–15% of patients experiencing urolithiasis during their lifetime. Additionally, the recurrence rate is very high, reaching about 50% within the past 10 years. Urolithiasis presents a very clinically important disease that can lead to renal colic, hematuria, or UTIs and cause serious complications, such as renal dysfunction or sepsis.
The treatment of urolithiasis has advanced remarkably over the past few decades and is still improving. Research on metabolic tests or drug treatment aiming to reduce the incidence or recurrence rate of this disease has been actively conducted, and drug research for medical expulsive therapy has also progressed significantly. Surgery has progressed due to the development of endoscopic equipment such as the ureterorenoscope and nephroscope; lithotripters, including lasers; and essential surgical equipment, such as stone baskets, guidewire, and access sheaths. In addition, extracorporeal shock wave lithotripsy has been continuously advanced through the development of lithotripsy and research on appropriate indications and shock wave frequency and time.
This Special Issue aims to provide an updated overview of urolithiasis and its treatment; to this end, we are inviting researchers from all over the world to submit relevant papers to this issue.
Dr. Dong Hyuk Kang
Dr. Hae Do Jung
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- percutaneous nephrolithotomy
- shockwave lithotripsy